Nexus Medical Partners is a Quincy, Massachusetts based private equity firm. Their investments are focused on medical technology, life science, advanced materials, software, communications, and information technology companies. They also work to provide strategic assistance to medical technology and life science companies.
Nexus Medical Partners has made investments in MTM Laboratories, Neurotech, Magellan Diagnostics, EyeGate Pharmaceuticals, Cequent Pharmaceuticals, Presidio Pharmaceuticals, Selah Technologies, Myoscience, Sabal Medical and Zipit Wireless.
They have exited their investments in Myoscience, EyeGate Pharmaceuticals, Presidio Pharmaceuticals, MTM Laboratories, Sabal Medical, Magellan Diagnostics, Cequent Pharmaceuticals and Selah Technologies.